...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Contribution of a Nuclear Factor-KAPPA?Binding Site to Human Angiotensinogen Promoter Activity in Renal Proximal Tubular Cells
【24h】

Contribution of a Nuclear Factor-KAPPA?Binding Site to Human Angiotensinogen Promoter Activity in Renal Proximal Tubular Cells

机译:肾近端肾小管细胞中核因子-KAPPA结合位点对人类血管紧张素原启动子活性的贡献

获取原文
获取原文并翻译 | 示例
           

摘要

Intrarenal angiotensinogen (AGT) is expressed highly in renal proximal tubular cells (RPTCs) and contributes to the regulation of intrarenal angiotensin II levels. Inhibition of nuclear factor (NF)-KAPPAB suppressed human (h)AGT expression in human RPTCs. However, the presence and localization of an NF-KAPPABbinding site in the hAGT promoter region have not been determined. Therefore, this study was performed to demonstrate that an NF-KAPPABbinding site in the hAGT promoter region contributes to hAGT promoter activity in human RPTCs. The hAGT promoter region was cloned from -4358 to +122 and deletion analysis was performed. A possible NF-kappaB binding site was removed from the hAGT promoter region (M1) and mutated (M2). Human RPTCs were transfected, and hAGT promoter activity was determined by luciferase assay. The identity of DNA binding proteins from binding assays were determined by Western blot. Progressive 5'-end deletions demonstrated removal of a distal promoter element in hAGT_-2414/+122 reduced promoter activity (0.61 +-0.12, ratio to hAGT_-4358/+122). Inhibition of NF-kappa suppressed promoter activity in hAGT_-4358/+122 (0.51 +-0.14, ratio to control) and hAGT_-3681/+122 (0.48+-0.06, ratio to control) but not in the construct without the NF-kappaB binding site. Promoter activity was reduced in the domain mutants Ml (0.57+-0.08, ratio to hAGT_-4358/+122) and M2 (0.61+-0.16, ratio to hAGT_-4358/+122). DNA binding levels of NF-KAPPA?protein were reduced in Ml. These data demonstrate the functional importance of an NF-KAPPA?binding site in the hAGT promoter region, which contributes to hAGT promoter activity in human RPTCs.
机译:肾内血管紧张素原(AGT)在肾近端肾小管细胞(RPTC)中高度表达,并有助于调节肾内血管紧张素II水平。抑制核因子(NF)-KAPPAB抑制了人类RPTC中人类(h)AGT的表达。但是,尚未确定在hAGT启动子区域中NF-KAPPAB结合位点的存在和定位。因此,进行该研究以证明hAGT启动子区域中的NF-KAPPAB结合位点有助于人RPTC中的hAGT启动子活性。将hAGT启动子区从-4358克隆至+122,并进行缺失分析。从hAGT启动子区域(M1)中删除了一个可能的NF-κB结合位点并进行了突变(M2)。将人RPTCs转染,并通过荧光素酶测定法确定hAGT启动子活性。通过Western印迹确定来自结合测定法的DNA结合蛋白的身份。渐进的5'-末端缺失证明了hAGT_-2414 / + 122中远端启动子元件的去除降低了启动子活性(0.61 + -0.12,与hAGT_-4358 / + 122的比率)。抑制NF-κB可抑制hAGT_-4358 / + 122(0.51 + -0.14,与对照之比)和hAGT_-3681 / + 122(0.48 + -0.06,与对照之比)中的启动子活性,但对没有NF的构建体不起作用-kappaB结合位点。结构域突变体M1(0.57 + -0.08,与hAGT_-4358 / + 122的比率)和M2(0.61 + -0.16,与hAGT_-4358 / + 122的比率)的启动子活性降低。 M1中NF-KAPPAβ蛋白的DNA结合水平降低。这些数据证明了hAGT启动子区域中NF-KAPPAβ结合位点的功能重要性,这有助于人RPTC中hAGT启动子的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号